drugset / Trial / NCT04114539
Ecopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label Extension
NaSingle-groupOpen-labelTreatment
Summary
This study was an international, multicenter, open-label, long term extension study evaluating the safety of ecopipam tablets for the treatment of children and adolescent subjects with Tourette Syndrome.
Timeline
- Start
- 2019-10-04
- Primary completion
- 2022-11-11
- Completion
- 2022-11-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ecopipam | Small molecule | 2 mg/kg | Oral |